Cameco Corp. buy BiotechBee
Start price
03.10.22
/
50%
€28.02
Target price
31.12.24
€37.00
Performance (%)
-26.25%
End price
21.12.22
€20.67
Summary
This prediction ended on 21.12.22 with a price of €20.67. The price of Cameco Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.25%. Dividends of €0.063 are taken into consideration when calculating the performance. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cameco Corp. | -6.209% | -6.209% | 9.391% | 151.676% |
| iShares Core DAX® | -1,02 % | -1,14 % | 1,59 % | 50,96 % |
| iShares Nasdaq 100 | -2,52 % | -5,25 % | 26,60 % | 82,15 % |
| iShares Nikkei 225® | -4,44 % | -10,16 % | 53,01 % | 68,74 % |
| iShares S&P 500 | -1,23 % | -0,04 % | 21,56 % | 65,37 % |
According to BiotechBee what are the pros and cons of Cameco Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Cameco Corp. diskutieren
Buy mit Kursziel 37,0